Rinat Eshel

448 total citations
19 papers, 325 citations indexed

About

Rinat Eshel is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rinat Eshel has authored 19 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Rinat Eshel's work include Glycosylation and Glycoproteins Research (8 papers), Cell Adhesion Molecules Research (5 papers) and Galectins and Cancer Biology (4 papers). Rinat Eshel is often cited by papers focused on Glycosylation and Glycoproteins Research (8 papers), Cell Adhesion Molecules Research (5 papers) and Galectins and Cancer Biology (4 papers). Rinat Eshel collaborates with scholars based in Israel, United States and Italy. Rinat Eshel's co-authors include Orit Sagi‐Assif, Isaac P. Witz, Ben‐Zion Katz, Ruud H. Brakenhoff, Guus A.M.S. van Dongen, Tal Freund, Yael Bar‐On, Odelia Amit, Chava Perry and David Hagin and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Rinat Eshel

18 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rinat Eshel Israel 9 147 119 87 79 40 19 325
Alexander Schultze Germany 10 111 0.8× 187 1.6× 50 0.6× 100 1.3× 17 0.4× 19 424
Adi Nagler Israel 9 103 0.7× 212 1.8× 121 1.4× 26 0.3× 31 0.8× 11 369
Bhumi Patel United States 7 78 0.5× 150 1.3× 80 0.9× 41 0.5× 105 2.6× 9 378
Peggy Richard-Fiardo France 8 193 1.3× 103 0.9× 139 1.6× 13 0.2× 13 0.3× 11 340
Petra Vrabcová Czechia 11 111 0.8× 93 0.8× 286 3.3× 93 1.2× 29 0.7× 16 450
Karin Purshouse United Kingdom 8 98 0.7× 176 1.5× 35 0.4× 37 0.5× 30 0.8× 19 323
Elena Agape Italy 6 85 0.6× 59 0.5× 102 1.2× 24 0.3× 27 0.7× 12 236
Chris Theodossiou United States 14 102 0.7× 132 1.1× 32 0.4× 15 0.2× 42 1.1× 24 380
Veronika Kanderová Czechia 12 46 0.3× 109 0.9× 231 2.7× 28 0.4× 62 1.6× 24 372
H Takagi Japan 7 54 0.4× 142 1.2× 149 1.7× 15 0.2× 19 0.5× 25 381

Countries citing papers authored by Rinat Eshel

Since Specialization
Citations

This map shows the geographic impact of Rinat Eshel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rinat Eshel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rinat Eshel more than expected).

Fields of papers citing papers by Rinat Eshel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rinat Eshel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rinat Eshel. The network helps show where Rinat Eshel may publish in the future.

Co-authorship network of co-authors of Rinat Eshel

This figure shows the co-authorship network connecting the top 25 collaborators of Rinat Eshel. A scholar is included among the top collaborators of Rinat Eshel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rinat Eshel. Rinat Eshel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ram, Ron, David Hagin, Tal Freund, et al.. (2021). Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study. Transplantation and Cellular Therapy. 27(9). 788–794. 94 indexed citations
2.
Luttwak, Efrat, David Hagin, Chava Perry, et al.. (2020). Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease—a single center case series. Bone Marrow Transplantation. 56(5). 1031–1037. 27 indexed citations
3.
Luttwak, Efrat, Odelia Amit, Irit Avivi, et al.. (2020). Bortezomib washout duration prior to stem cell mobilization in patients with newly diagnosed multiple myeloma. European Journal Of Haematology. 105(1). 30–34. 2 indexed citations
4.
Eshel, Rinat, Albert Pinhasov, Menachem Bitan, et al.. (2018). Significant correlation between peripheral blood CD34+ cell count in children prior to aphaeresis and CD34+ cell yield following aphaeresis: A single‐center experience. Pediatric Transplantation. 22(3). e13150–e13150. 2 indexed citations
5.
Perry, Chava, Yair Herishanu, Nadav Sarid, et al.. (2017). Toxicity and efficacy of autologous hematopoietic cell transplantation in elderly patients with aggressive lymphoma: a historical prospective study. Annals of Hematology. 97(3). 459–466.
6.
Bitan, Menachem, Rinat Eshel, Shirley Friedman, et al.. (2016). Combined plerixafor and granulocyte colony‐stimulating factor for harvesting high‐dose hematopoietic stem cells: Possible niche for plerixafor use in pediatric patients. Pediatric Transplantation. 20(4). 565–571. 7 indexed citations
7.
Sarid, Nadav, Rinat Eshel, Ilya Kirgner, et al.. (2013). JAK2 mutation: an aid in the diagnosis of occult myeloproliferative neoplasms in patients with major intraabdominal vein thrombosis and normal blood counts.. PubMed. 15(11). 698–700. 5 indexed citations
9.
Eshel, Rinat, Yona Nadir, Saverio Minucci, et al.. (2005). Leukomogenic factors downregulate heparanase expression in acute myeloid leukemia cells. Biochemical and Biophysical Research Communications. 335(4). 1115–1122. 6 indexed citations
10.
Naparstek, Elizabeth, et al.. (2004). Generation of Human Anti-Leukemia CTL Vaccine Utilizing Dendritic Cell Hybrids.. Blood. 104(11). 2539–2539. 3 indexed citations
11.
Vlodavsky, Israël, Eyal Zcharia, Orit Goldshmidt, et al.. (2003). Involvement of Heparanase in Tumor Progression and Normal Differentiation. Pathophysiology of Haemostasis and Thrombosis. 33(1). 59–61. 6 indexed citations
12.
Eshel, Rinat, et al.. (2002). Human Ly‐6 antigen E48 (Ly‐6D) regulates important interaction parameters between endothelial cells and head‐and‐neck squamous carcinoma cells. International Journal of Cancer. 98(6). 803–810. 37 indexed citations
13.
Eshel, Rinat, Eran Neumark, Orit Sagi‐Assif, & Isaac P. Witz. (2002). Receptors involved in microenvironment-driven molecular evolution of cancer cells. Seminars in Cancer Biology. 12(2). 139–147. 9 indexed citations
14.
Eshel, Rinat, et al.. (2001). The FX Enzyme Is a Functional Component of Lymphocyte Activation. Cellular Immunology. 213(2). 141–148. 13 indexed citations
15.
Eshel, Rinat, Orit Sagi‐Assif, Nechama I. Smorodinsky, et al.. (2000). The GPI-linked Ly-6 Antigen E48 Regulates Expression Levels of the FX Enzyme and of E-selectin Ligands on Head and Neck Squamous Carcinoma Cells. Journal of Biological Chemistry. 275(17). 12833–12840. 28 indexed citations
16.
Sagi‐Assif, Orit, Nechama I. Smorodinsky, Itshak Golan, et al.. (1998). Expression of Ly-6, a marker for highly malignant murine tumor cells, is regulated by growth conditions and stress. International Journal of Cancer. 77(2). 306–313. 36 indexed citations
17.
Zusman, Tal, et al.. (1997). The tumorigenic phenotype of a mutated form of Fc gamma RIIB1, lacking the ability to generate soluble receptor and allowing a low-level of ligand binding. International Journal of Oncology. 11(4). 857–61. 1 indexed citations
18.
Eshel, Rinat, et al.. (1995). Microenvironmental factors regulate Ly-6 A/E expression on Py V-transformed BALB/c 3T3 cells. Immunology Letters. 44(2-3). 209–212. 7 indexed citations
19.
Katz, Ben‐Zion, Rinat Eshel, Orit Sagi‐Assif, & Isaac P. Witz. (1994). AN association between high Ly‐6A/E expression on tumor cells and a highly malignant phenotype. International Journal of Cancer. 59(5). 684–691. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026